Abstract: Autoimmune reactions to certain epitopes of self antigens most likely contribute to the development of rheumatoid arthritis. Often these epitopes are citrullinated. The present invention relates generally to novel antibodies that can bind to certain citrullinated epitopes namely citrullinated enolase, vimentin, fibrinogen and citrullinated synthetic peptides. These antibodies can be used in diagnostics of rheumatoid arthritis, for therapy against rheumatoid arthritis and as research tools.
Type:
Application
Filed:
July 17, 2014
Publication date:
February 26, 2015
Applicant:
VILARA AB
Inventors:
Lars Klareskog, Vivianne Malmström, Khaled Amara